Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites
Sanjay Varikuti, Bijay Kumar Jha, Greta Volpedo, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Anti-trypanosomatid drug discovery: progress and challenges
Manu De Rycker, Susan Wyllie, David Horn, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 35-50
Open Access | Times Cited: 126
Fucoidans: Downstream Processes and Recent Applications
Ahmed Zayed, Roland Ulber
Marine Drugs (2020) Vol. 18, Iss. 3, pp. 170-170
Open Access | Times Cited: 72
Advancement in leishmaniasis diagnosis and therapeutics: An update
Diksha Kumari, Summaya Perveen, Rashmi Sharma, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174436-174436
Closed Access | Times Cited: 61
Technological Innovations in Tropical Diseases Treatment and Therapeutics
Matthew Chidozie Ogwu, Sylvester Chibueze Izah
Health information science (2025), pp. 287-308
Closed Access | Times Cited: 1
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Elisa Escabia, et al.
Research and Reports in Tropical Medicine (2023) Vol. Volume 14, pp. 1-19
Open Access | Times Cited: 19
Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Miebaka Jamabo, Maduma Ernst Mahlalela, Adrienne L. Edkins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12529-12529
Open Access | Times Cited: 17
The antimicrobial activity of innate host-directed therapies: A systematic review
Tirosh Shapira, Matthew Christofferson, Yossef Av‐Gay
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107138-107138
Open Access | Times Cited: 6
Future applications of host direct therapies for infectious disease treatment
Ruth Thom, Riccardo V. D’Elia
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Host-directed therapy, an untapped opportunity for antimalarial intervention
Ling Wei, Jack Adderley, Didier Leroy, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100423-100423
Open Access | Times Cited: 35
Modulation of Inflammation and Immune Responses by Heme Oxygenase-1: Implications for Infection with Intracellular Pathogens
Diego L. Costa, Eduardo P. Amaral, Bruno B. Andrade, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1205-1205
Open Access | Times Cited: 33
Innate immune cell response to host-parasite interaction in a human intestinal tissue microphysiological system
Mouhita Humayun, José M. Ayuso, Keon Young Park, et al.
Science Advances (2022) Vol. 8, Iss. 18
Open Access | Times Cited: 22
Privileged small molecules against neglected tropical diseases: A perspective from structure activity relationships
Jafar Abbasi Shiran, Babak Kaboudin, Nasrin Panahi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116396-116396
Closed Access | Times Cited: 4
Assessment of efficacy and safety of imatinib as an adjunct host-targeted therapy for parasite clearance in chloroquine-resistant malaria: a prospective case control study
Fazeel Zubair Ahmed, Pavagada Shaifulla
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access
Review of host-directed immunotherapy and candidate agents against leishmaniasis
Mebratu Tamir, Bisrat Birke Teketelew, Dereje Mengesha Berta, et al.
Frontiers in Tropical Diseases (2025) Vol. 6
Open Access
Comprehensive insights into leishmaniasis: From etiopathogenesis to a novel therapeutic approach
Zarbakht Ansari Pirsaraei, Ajeet Kumar Chaurasia, Neha Bhutiani, et al.
Microbial Pathogenesis (2025), pp. 107535-107535
Closed Access
Leishmania donovani Internalizes into Host Cells via Caveolin-mediated Endocytosis
G. Aditya Kumar, Joyshree Karmakar, Chitra Mandal, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 30
A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patients
Kevin Roe
Journal of Neuroscience Research (2021) Vol. 99, Iss. 10, pp. 2367-2376
Open Access | Times Cited: 24
Expanding Bromodomain Targeting into Neglected Parasitic Diseases
C. Tallant, Paul Bamborough, Chun‐wa Chung, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 11, pp. 2953-2958
Closed Access | Times Cited: 24
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni
Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 7, pp. 1356-1366
Open Access | Times Cited: 18
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease
Zongyuan Liu, Rebecca Ulrich vonBargen, April Kendricks, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis
Thalia Pacheco‐Fernández, Greta Volpedo, Chaitenya Verma, et al.
Biochemical Society Transactions (2021) Vol. 49, Iss. 1, pp. 297-311
Closed Access | Times Cited: 22
Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis
Alexandra Ibáñez‐Escribano, Cristina Fonseca‐Berzal, Mónica Martínez-Montiel, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 781-791
Open Access | Times Cited: 14
The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections
Kevin Roe
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 3, pp. 513-516
Open Access | Times Cited: 19
Quinoxalines against Leishmania amazonensis: SAR study, proposition of a new derivative, QSAR prediction, synthesis, and biological evaluation
Anna Carolina Silva de Jesus Passaes, Juliana A. Dantas, Fernanda Landim Lopes, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
Nathan Ryan, Kelvin Anderson, Greta Volpedo, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top